Highly Selective, Amine‐Derived Cannabinoid Receptor 2 Probes. Issue 6 (21st January 2020)

• Record Type: Journal Article
• Authors: Westphal, Matthias V.; Sarott, Roman C.; Zirwes, Elisabeth A.; Osterwald, Anja; Guba, Wolfgang; Ullmer, Christoph; Grether, Uwe; Carreira, Erick M.
• Is Part Of: Chemistry. Volume 26:Issue 6(2020)
• Page Start: 1380
• Page End: 1387
• Publication Date: 2020-01-21
• Subjects: cannabinoid receptor 2 -- CB2R -- chemical probe -- electrophilic ligands -- endocannabinoid system -- fluorescent probe; Chemistry -- Periodicals; 540
• DOI: 10.1002/chem.201904584
• Languages: English
• ISSNs: 0947-6539

Abstract

Abstract: The endocannabinoid (eCB) system is implied in various human diseases ranging from central nervous system to autoimmune disorders. Cannabinoid receptor 2 (CB2 R) is an integral component of the eCB system. Yet, the downstream effects elicited by this G protein‐coupled receptor upon binding of endogenous or synthetic ligands are insufficiently understood—likely due to the limited arsenal of reliable biological and chemical tools. Herein, we report the design and synthesis of CB2 R‐selective cannabinoids along with their in vitro pharmacological characterization (binding and functional studies). They combine structural features of HU‐308 and AM841 to give chimeric ligands that emerge as potent CB2 R agonists with high selectivity over the closely related cannabinoid receptor 1 (CB1 R). The synthesis work includes convenient preparation of substituted resorcinols often found in cannabinoids. The utility of the synthetic cannabinoids in this study is showcased by preparation of the most selective high‐affinity fluorescent probe for CB2 R to date. Abstract : The design and synthesis of CB2 R‐selective cannabinoids along with their in vitro pharmacological characterization (binding and functional studies) is reported. Chimeric ligands emerge as potent CB2 R agonists with high selectivity over the closely related cannabinoid receptor 1 (CB1 R).